
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
Marco Maugeri, Muhammad Nawaz, Alexandros Papadimitriou, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 320
Marco Maugeri, Muhammad Nawaz, Alexandros Papadimitriou, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 320
Showing 1-25 of 320 citing articles:
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 101-124
Open Access | Times Cited: 5255
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 101-124
Open Access | Times Cited: 5255
RNA delivery by extracellular vesicles in mammalian cells and its applications
Killian P. O’Brien, Koen Breyne, Stefano Ughetto, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 585-606
Open Access | Times Cited: 1409
Killian P. O’Brien, Koen Breyne, Stefano Ughetto, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 585-606
Open Access | Times Cited: 1409
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang, Xiao-Feng Li, Yong‐Qiang Deng, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1271-1283.e16
Open Access | Times Cited: 616
Na-Na Zhang, Xiao-Feng Li, Yong‐Qiang Deng, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1271-1283.e16
Open Access | Times Cited: 616
Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 457
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 457
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Eleni Samaridou, James Heyes, Peter Lutwyche
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 37-63
Closed Access | Times Cited: 440
Eleni Samaridou, James Heyes, Peter Lutwyche
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 37-63
Closed Access | Times Cited: 440
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103479-103479
Open Access | Times Cited: 401
Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103479-103479
Open Access | Times Cited: 401
Nanodelivery of nucleic acids
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 382
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 382
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 310
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 310
Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles
Federica Sebastiani, Marianna Yanez Arteta, Michael Lerche, et al.
ACS Nano (2021) Vol. 15, Iss. 4, pp. 6709-6722
Open Access | Times Cited: 249
Federica Sebastiani, Marianna Yanez Arteta, Michael Lerche, et al.
ACS Nano (2021) Vol. 15, Iss. 4, pp. 6709-6722
Open Access | Times Cited: 249
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
Michele Schlich, Roberto Palomba, Gabriella Costabile, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 237
Michele Schlich, Roberto Palomba, Gabriella Costabile, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 237
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 217
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 217
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 202
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 202
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
María L. Guevara, Francesca Persano, Stefano Persano
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 201
María L. Guevara, Francesca Persano, Stefano Persano
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 201
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs
Yuta Suzuki, Hiroshi Ishihara
Drug Metabolism and Pharmacokinetics (2021) Vol. 41, pp. 100424-100424
Open Access | Times Cited: 183
Yuta Suzuki, Hiroshi Ishihara
Drug Metabolism and Pharmacokinetics (2021) Vol. 41, pp. 100424-100424
Open Access | Times Cited: 183
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Lucia Salvioni, Maria Antonietta Rizzuto, Jessica Bertolini, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1855-1855
Open Access | Times Cited: 177
Lucia Salvioni, Maria Antonietta Rizzuto, Jessica Bertolini, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1855-1855
Open Access | Times Cited: 177
The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA
Pratikkumar Patel, Nurudeen Mohammed Ibrahim, Kun Cheng
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 6, pp. 448-460
Open Access | Times Cited: 162
Pratikkumar Patel, Nurudeen Mohammed Ibrahim, Kun Cheng
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 6, pp. 448-460
Open Access | Times Cited: 162
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
István Tombácz, Dorottya Laczkó, Hamna Shahnawaz, et al.
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3293-3304
Open Access | Times Cited: 155
István Tombácz, Dorottya Laczkó, Hamna Shahnawaz, et al.
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3293-3304
Open Access | Times Cited: 155
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 141
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 141
Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
Alberto Cagigi, Karin Loré
Vaccines (2021) Vol. 9, Iss. 1, pp. 61-61
Open Access | Times Cited: 137
Alberto Cagigi, Karin Loré
Vaccines (2021) Vol. 9, Iss. 1, pp. 61-61
Open Access | Times Cited: 137
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities
Anika Nagelkerke, Miina Ojansivu, Luke van der Koog, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113775-113775
Open Access | Times Cited: 131
Anika Nagelkerke, Miina Ojansivu, Luke van der Koog, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113775-113775
Open Access | Times Cited: 131
Delivery Strategies for mRNA Vaccines
Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta
Pharmaceutical Medicine (2022) Vol. 36, Iss. 1, pp. 11-20
Open Access | Times Cited: 129
Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta
Pharmaceutical Medicine (2022) Vol. 36, Iss. 1, pp. 11-20
Open Access | Times Cited: 129
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 128
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 128
Natural or Synthetic RNA Delivery: A Stoichiometric Comparison of Extracellular Vesicles and Synthetic Nanoparticles
Daniel E. Murphy, Olivier G. de Jong, Martijn J.W. Evers, et al.
Nano Letters (2021) Vol. 21, Iss. 4, pp. 1888-1895
Open Access | Times Cited: 118
Daniel E. Murphy, Olivier G. de Jong, Martijn J.W. Evers, et al.
Nano Letters (2021) Vol. 21, Iss. 4, pp. 1888-1895
Open Access | Times Cited: 118
Endosomal escape: A bottleneck for LNP-mediated therapeutics
Sushmita Chatterjee, Edo Kon, Preeti Sharma, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 118
Sushmita Chatterjee, Edo Kon, Preeti Sharma, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 118
Exosomes based strategies for brain drug delivery
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 117
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 117